In a groundbreaking development, the World Health Organization (WHO) has announced a major breakthrough in the field of cancer treatment. The announcement was made during a press conference held at WHO headquarters earlier today.
The new treatment method involves using nano-robots to deliver targeted doses of chemotherapy directly to tumor cells while minimizing damage to healthy tissue. This innovative approach is expected to significantly reduce side effects associated with traditional treatments and improve overall patient prognosis.
Dr. Maria Van Kerkhove, Head of Emerging Diseases and Zoonosis Unit at WHO, expressed her enthusiasm for this revolutionary technology: "This is an extraordinary step forward for medicine and our ongoing battle against cancer. By delivering highly targeted chemotherapy through these nano-robots, we are able not only to minimize collateral damage but also maximize efficacy."
The research leading up to this discovery involved collaboration between several international institutions including Johns Hopkins University School of Medicine and the Swiss Federal Institute of Technology Lausanne (EPFL). Dr. Carl June from Johns Hopkins explained that years-long efforts have finally paid off: "We've been working tirelessly on developing these nano-robots since 2012, and witnessing their potential impact on patients' lives makes it all worthwhile."
Clinical trials involving human subjects are set to begin within six months following approval by regulatory authorities worldwide. If successful, experts predict that this could pave the way for further advancements such as personalized drug delivery systems tailored specifically toward individual patients' needs.
Cancer survivor Natasha Richardson shared her thoughts about what this could mean for others battling the disease: "As someone who's experienced firsthand how grueling conventional treatments can be – physically as well as emotionally – I'm incredibly hopeful that future generations will benefit from less invasive methods like those being developed now."